Viewing StudyNCT00233064



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00233064
Status: COMPLETED
Last Update Posted: 2018-06-27
First Post: 2005-10-03

Brief Title: Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab MEDI-493 Synagis
Sponsor: MedImmune LLC
Organization: MedImmune LLC

Organization Data

Organization: MedImmune LLC
Class: INDUSTRY
Study ID: MI-CP116
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MedImmune LLC
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Genevieve Losonsky MD
Old Organization: MedImmune Inc

Collaborators